These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 1023470

  • 21. Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.
    Rodriguez M, Patick AK, Pease LR, David CS.
    J Immunol; 1992 Feb 01; 148(3):921-7. PubMed ID: 1309845
    [Abstract] [Full Text] [Related]

  • 22. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
    Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R.
    J Immunol; 1993 Jul 01; 151(1):266-76. PubMed ID: 8326128
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.
    Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD.
    J Immunol; 1995 Jul 15; 155(2):947-57. PubMed ID: 7608570
    [Abstract] [Full Text] [Related]

  • 24. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
    Rodriguez M, Oleszak E, Leibowitz J.
    Crit Rev Immunol; 1987 Jul 15; 7(4):325-65. PubMed ID: 2827957
    [Abstract] [Full Text] [Related]

  • 25. A new model of persistent viral infection with primary demyelination.
    dal Canto MC, Lipton HL.
    Neurol Neurocir Psiquiatr; 1977 Jul 15; 18(2-3 Suppl):455-67. PubMed ID: 616547
    [Abstract] [Full Text] [Related]

  • 26. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
    Cash E, Bandeira A, Chirinian S, Brahic M.
    J Immunol; 1989 Aug 01; 143(3):984-8. PubMed ID: 2545781
    [Abstract] [Full Text] [Related]

  • 27. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.
    Lipton HL.
    Infect Immun; 1975 May 01; 11(5):1147-55. PubMed ID: 164412
    [Abstract] [Full Text] [Related]

  • 28. Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice.
    Patick AK, Oleszak EL, Leibowitz JL, Rodriguez M.
    J Gen Virol; 1990 Sep 01; 71 ( Pt 9)():2123-32. PubMed ID: 2212994
    [Abstract] [Full Text] [Related]

  • 29. Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus.
    Sethi P, Lipton HL.
    Br J Exp Pathol; 1983 Feb 01; 64(1):57-65. PubMed ID: 6301522
    [Abstract] [Full Text] [Related]

  • 30. Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination.
    Rodriguez M, Nickerson C, Patick AK, David CS.
    J Immunol; 1991 Apr 15; 146(8):2596-602. PubMed ID: 2016520
    [Abstract] [Full Text] [Related]

  • 31. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6.
    Melvold RW, Jokinen DM, Knobler RL, Lipton HL.
    J Immunol; 1987 Mar 01; 138(5):1429-33. PubMed ID: 3027179
    [Abstract] [Full Text] [Related]

  • 32. Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and -resistant strains of mice.
    Rubio N, Capa L.
    Cell Immunol; 1993 Jul 01; 149(2):237-47. PubMed ID: 8330309
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Contrasting effects of immunosuppression on Theiler's virus infection in mice.
    Lipton HL, Canto CD.
    Infect Immun; 1977 Mar 01; 15(3):903-9. PubMed ID: 192679
    [Abstract] [Full Text] [Related]

  • 36. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE.
    Barbano RL, Dal Canto MC.
    J Neurol Sci; 1984 Mar 01; 66(2-3):283-93. PubMed ID: 6085111
    [Abstract] [Full Text] [Related]

  • 37. Role of the humoral immune response in resistance to Theiler's virus infection.
    Rossi CP, Cash E, Aubert C, Coutinho A.
    J Virol; 1991 Jul 01; 65(7):3895-9. PubMed ID: 1645797
    [Abstract] [Full Text] [Related]

  • 38. Neuronal and oligodendroglial infection by the WW strain of Theiler's virus.
    Penney JB, Wolinsky JS.
    Lab Invest; 1979 Mar 01; 40(3):324-30. PubMed ID: 423527
    [Abstract] [Full Text] [Related]

  • 39. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection.
    Dal Canto MC, Lipton HL.
    Am J Pathol; 1982 Jan 01; 106(1):20-9. PubMed ID: 6275708
    [Abstract] [Full Text] [Related]

  • 40. Virus-associated immunopathology: animal models and implications for human disease. 1. Effects of viruses on the immune system, immune-complex diseases, and antibody-mediated immunologic injury.
    Allison AC, Beveridge WI, Cockburn WC, East J, Goodman HC, Koprowski H, Lambert PH, van Lochem JJ, Miescher PA, Mimms CA, Notkins AL, Torrigiani G.
    Bull World Health Organ; 1972 Jan 01; 47(2):257-64. PubMed ID: 4404992
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.